Publication & Citation Trends
Publications
0 total
Abstract 5365: Prolonged survival of patients with advanced renal cancer responding to multi-peptide vaccine IMA901 after single-dose cyclophosphamide
Cited by 1
Semantic Scholar
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival OA
Cited by 833
Semantic Scholar
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.
Cited by 638
Semantic Scholar
Randomized double-blind placebo-controlled international trial of abagovomab maintenance therapy in patients with advanced ovarian cancer after complete response to first-line chemotherapy: The Monoclonal Antibody Immunotherapy for Malignancies of the Ovary by Subcutaneous Abagovomab (MIMOSA) trial.
Cited by 11
Semantic Scholar
Abagovomab maintenance therapy in patients with epithelial ovarian cancer after complete response (CR) post-first-line chemotherapy (FLCT): Preliminary results of the randomized, double-blind, placebo-controlled, multicenter MIMOSA trial.
Cited by 10
Semantic Scholar
A multicentre phase II gene expression profiling study of putative relationships between tumour biomarkers and clinical response with erlotinib in non-small-cell lung cancer OA
Cited by 44
Semantic Scholar
A randomized, open-label, phase III trial of NOV-002 in combination with paclitaxel (P) and carboplatin (C) versus paclitaxel and carboplatin alone for the treatment of advanced non-small cell lung cancer (NSCLC).
Cited by 6
Semantic Scholar
Research Topics
Cancer Treatment and Pharmacology
(27)
Lung Cancer Treatments and Mutations
(21)
Lymphoma Diagnosis and Treatment
(17)
Breast Cancer Treatment Studies
(16)
HER2/EGFR in Cancer Research
(11)
Affiliations
BC Cancer Agency
University of Helsinki
Uppsala University Hospital
Heidelberg University
Leicester Royal Infirmary